News Roundup: November 28 to December 2
Your weekly roundup of the latest news from Drug Topics®.
Global Measles Threat Increases Due to Decline in Vaccine Coverage
The COVID-19 pandemic disrupted routine immunization programs around the world.
Black Patients Face Disparities for CGMs, Insulin Pumps
New research adds more evidence of Black patients facing disparities in diabetes care.
Recession Ahead: How to Prepare Your Pharmacy
Many independent pharmacies closed during the last recession.
Looking at Barriers to Childhood Vaccinations
A recent poll showed that some parents do not discuss vaccines with their child’s regular doctor, with many choosing to not have their child receive any vaccines.
AI Pricing Tools and Technology in the Pharmacy
Drug Topics® talks with pharmacy owner Jeff Harrell about AI pricing tools and technology in the pharmacy.
FDA Approves Lebrikizumab-lbkz for Moderate-to-Severe Atopic Dermatitis
September 16th 2024Lebrikizumab-lbks is a targeted treatment that addresses the root cause of atopic dermatitis; by reducing inflammation throughout the body, it can help alleviate the dry, itchy, and irritated skin that often characterizes the condition.
